Gossamer Price To Sales Ratio vs Book Value Per Share Analysis

GOSS Stock

USD 2.71 0.20 7.97%

Gossamer Bio financial indicator trend analysis is much more than just examining Gossamer Bio latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Gossamer Bio is a good investment. Please check the relationship between Gossamer Bio Price To Sales Ratio and its Book Value Per Share accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Gossamer Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

For more information on how to buy Gossamer Stock please use our How to Invest in Gossamer Bio guide.

Price To Sales Ratio vs Book Value Per Share

Price To Sales Ratio vs Book Value Per Share Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Gossamer Bio Price To Sales Ratio account and Book Value Per Share. At this time, the significance of the direction appears to have almost no relationship.

The correlation between Gossamer Bio's Price To Sales Ratio and Book Value Per Share is 0.1. Overlapping area represents the amount of variation of Price To Sales Ratio that can explain the historical movement of Book Value Per Share in the same time period over historical financial statements of Gossamer Bio, assuming nothing else is changed. The correlation between historical values of Gossamer Bio's Price To Sales Ratio and Book Value Per Share is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Price To Sales Ratio of Gossamer Bio are associated (or correlated) with its Book Value Per Share. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Book Value Per Share has no effect on the direction of Price To Sales Ratio i.e., Gossamer Bio's Price To Sales Ratio and Book Value Per Share go up and down completely randomly.

Correlation Coefficient

0.1

Relationship Direction	Positive
Relationship Strength	Insignificant

View All Relationships

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Gossamer Bio stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Gossamer Bio sales, a figure that is much harder to manipulate than other Gossamer Bio multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Book Value Per Share

The ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements.

Most indicators from Gossamer Bio's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Gossamer Bio current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Gossamer Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

For more information on how to buy Gossamer Stock please use our How to Invest in Gossamer Bio guide.At this time, Gossamer Bio's Selling General Administrative is comparatively stable compared to the past year. Tax Provision is likely to gain to about 937.6 K in 2025, whereas Sales General And Administrative To Revenue is likely to drop 0.26 in 2025.

Gossamer Bio fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Cash	Long Term Debt	Cash And Short Term Investments	Common Stock Shares Outstanding	Long Term Debt Total	Non Current Liabilities Total	Total Liab	Total Current Assets	Other Liab	Capital Surpluse	Other Current Assets	Other Stockholder Equity	Net Invested Capital	Net Working Capital	Property Plant And Equipment Net	Other Assets	Net Receivables
Total Assets		0.79	0.93	0.9	0.69	0.66	-0.19	-0.72	0.83	0.79	0.77	1.0	0.6	0.92	0.72	0.77	1.0	0.92	0.85	0.94	0.83	0.89	1.0	0.85	-0.84	0.42
Short Long Term Debt Total	0.79		0.86	0.94	0.32	0.26	0.28	-0.94	0.77	0.52	1.0	0.79	0.77	0.84	0.76	0.81	0.79	0.84	0.96	0.89	0.96	0.76	0.76	0.54	-0.93	0.7
Other Current Liab	0.93	0.86		0.97	0.54	0.5	0.09	-0.83	0.71	0.59	0.85	0.93	0.67	0.95	0.75	0.81	0.93	0.95	0.91	0.92	0.9	0.83	0.92	0.76	-0.9	0.56
Total Current Liabilities	0.9	0.94	0.97		0.46	0.4	0.21	-0.91	0.74	0.53	0.93	0.9	0.78	0.94	0.78	0.84	0.9	0.94	0.97	0.96	0.96	0.82	0.88	0.66	-0.95	0.69
Total Stockholder Equity	0.69	0.32	0.54	0.46		0.99	-0.47	-0.23	0.51	0.71	0.31	0.69	0.1	0.4	0.0	0.08	0.69	0.4	0.5	0.56	0.46	0.85	0.7	0.9	-0.48	-0.04
Net Tangible Assets	0.66	0.26	0.5	0.4	0.99		-0.53	-0.16	0.45	0.72	0.25	0.66	0.02	0.35	-0.04	0.03	0.65	0.36	0.44	0.5	0.39	0.81	0.67	0.9	-0.41	-0.11
Net Debt	-0.19	0.28	0.09	0.21	-0.47	-0.53		-0.51	-0.2	-0.66	0.29	-0.19	0.57	0.12	0.1	0.12	-0.18	0.11	0.25	0.12	0.32	-0.11	-0.21	-0.42	-0.33	0.74
Retained Earnings	-0.72	-0.94	-0.83	-0.91	-0.23	-0.16	-0.51		-0.65	-0.29	-0.94	-0.72	-0.92	-0.85	-0.72	-0.77	-0.72	-0.85	-0.92	-0.89	-0.95	-0.69	-0.7	-0.42	0.96	-0.87
Accounts Payable	0.83	0.77	0.71	0.74	0.51	0.45	-0.2	-0.65		0.78	0.77	0.83	0.59	0.72	0.67	0.7	0.83	0.72	0.72	0.82	0.73	0.75	0.83	0.59	-0.72	0.32
Cash	0.79	0.52	0.59	0.53	0.71	0.72	-0.66	-0.29	0.78		0.51	0.79	0.12	0.55	0.45	0.48	0.79	0.55	0.52	0.6	0.46	0.73	0.8	0.82	-0.45	-0.09
Long Term Debt	0.77	1.0	0.85	0.93	0.31	0.25	0.29	-0.94	0.77	0.51		0.77	0.77	0.83	0.74	0.8	0.78	0.83	0.95	0.89	0.95	0.75	0.75	0.52	-0.93	0.7
Cash And Short Term Investments	1.0	0.79	0.93	0.9	0.69	0.66	-0.19	-0.72	0.83	0.79	0.77		0.6	0.92	0.72	0.77	1.0	0.92	0.85	0.93	0.83	0.89	1.0	0.85	-0.84	0.41
Common Stock Shares Outstanding	0.6	0.77	0.67	0.78	0.1	0.02	0.57	-0.92	0.59	0.12	0.77	0.6		0.78	0.66	0.7	0.61	0.78	0.76	0.81	0.83	0.53	0.6	0.21	-0.86	0.89
Long Term Debt Total	0.92	0.84	0.95	0.94	0.4	0.35	0.12	-0.85	0.72	0.55	0.83	0.92	0.78		0.86	0.9	0.92	1.0	0.86	0.92	0.86	0.73	0.91	0.64	-0.88	0.64
Non Current Liabilities Total	0.72	0.76	0.75	0.78	0.0	-0.04	0.1	-0.72	0.67	0.45	0.74	0.72	0.66	0.86		0.99	0.72	0.87	0.67	0.73	0.67	0.38	0.7	0.31	-0.64	0.52
Total Liab	0.77	0.81	0.81	0.84	0.08	0.03	0.12	-0.77	0.7	0.48	0.8	0.77	0.7	0.9	0.99		0.77	0.9	0.73	0.79	0.74	0.46	0.75	0.38	-0.71	0.56
Total Current Assets	1.0	0.79	0.93	0.9	0.69	0.65	-0.18	-0.72	0.83	0.79	0.78	1.0	0.61	0.92	0.72	0.77		0.92	0.85	0.94	0.83	0.89	1.0	0.85	-0.84	0.42
Other Liab	0.92	0.84	0.95	0.94	0.4	0.36	0.11	-0.85	0.72	0.55	0.83	0.92	0.78	1.0	0.87	0.9	0.92		0.86	0.93	0.86	0.73	0.92	0.65	-0.88	0.64
Capital Surpluse	0.85	0.96	0.91	0.97	0.5	0.44	0.25	-0.92	0.72	0.52	0.95	0.85	0.76	0.86	0.67	0.73	0.85	0.86		0.95	0.99	0.86	0.82	0.65	-0.97	0.69
Other Current Assets	0.94	0.89	0.92	0.96	0.56	0.5	0.12	-0.89	0.82	0.6	0.89	0.93	0.81	0.92	0.73	0.79	0.94	0.93	0.95		0.95	0.87	0.92	0.68	-0.95	0.66
Other Stockholder Equity	0.83	0.96	0.9	0.96	0.46	0.39	0.32	-0.95	0.73	0.46	0.95	0.83	0.83	0.86	0.67	0.74	0.83	0.86	0.99	0.95		0.84	0.81	0.6	-0.98	0.75
Net Invested Capital	0.89	0.76	0.83	0.82	0.85	0.81	-0.11	-0.69	0.75	0.73	0.75	0.89	0.53	0.73	0.38	0.46	0.89	0.73	0.86	0.87	0.84		0.88	0.9	-0.85	0.4
Net Working Capital	1.0	0.76	0.92	0.88	0.7	0.67	-0.21	-0.7	0.83	0.8	0.75	1.0	0.6	0.91	0.7	0.75	1.0	0.92	0.82	0.92	0.81	0.88		0.85	-0.83	0.4
Property Plant And Equipment Net	0.85	0.54	0.76	0.66	0.9	0.9	-0.42	-0.42	0.59	0.82	0.52	0.85	0.21	0.64	0.31	0.38	0.85	0.65	0.65	0.68	0.6	0.9	0.85		-0.63	0.11
Other Assets	-0.84	-0.93	-0.9	-0.95	-0.48	-0.41	-0.33	0.96	-0.72	-0.45	-0.93	-0.84	-0.86	-0.88	-0.64	-0.71	-0.84	-0.88	-0.97	-0.95	-0.98	-0.85	-0.83	-0.63		-0.78
Net Receivables	0.42	0.7	0.56	0.69	-0.04	-0.11	0.74	-0.87	0.32	-0.09	0.7	0.41	0.89	0.64	0.52	0.56	0.42	0.64	0.69	0.66	0.75	0.4	0.4	0.11	-0.78

Click cells to compare fundamentals

Gossamer Bio Account Relationship Matchups

Gossamer Bio fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	539.4M	343.7M	272.5M	311.9M	315.3M	299.4M
Short Long Term Debt Total	183.7M	185.2M	225.7M	212.5M	202.9M	145.2M
Other Current Liab	27.5M	33.7M	33.2M	31.2M	24.7M	24.9M
Total Current Liabilities	38.7M	39.9M	49.2M	51.6M	45.0M	34.6M
Total Stockholder Equity	320.7M	121.5M	12.1M	62.8M	29.5M	28.0M
Net Tangible Assets	352.5M	320.7M	121.5M	12.1M	13.9M	13.2M
Net Debt	(302.3M)	1.8M	113.8M	180.4M	156.8M	164.6M
Retained Earnings	(577.5M)	(811.5M)	(1.0B)	(1.2B)	(1.3B)	(1.2B)
Accounts Payable	7.5M	3.2M	1.5M	5.5M	2.3M	2.9M
Cash	486.1M	183.4M	112.0M	32.1M	46.1M	43.8M
Non Current Assets Total	17.1M	11.9M	10.6M	5.4M	5.4M	9.2M
Non Currrent Assets Other	1.0M	1.1M	680K	618K	283K	268.9K
Long Term Debt	172.4M	179.1M	207.7M	197.4M	197.5M	135.9M
Cash And Short Term Investments	512.6M	325.2M	255.7M	296.4M	294.5M	283.0M
Common Stock Shares Outstanding	68.5M	74.8M	84.6M	225.6M	226.2M	237.5M
Short Term Investments	26.6M	141.8M	143.7M	264.3M	248.4M	148.5M
Liabilities And Stockholders Equity	539.4M	343.7M	272.5M	311.9M	315.3M	299.4M
Non Current Liabilities Total	180.1M	182.3M	211.1M	197.5M	240.8M	170.4M
Total Liab	218.7M	222.2M	260.4M	249.1M	285.8M	205.0M
Total Current Assets	522.3M	331.8M	261.9M	306.5M	309.9M	290.2M
Capital Surpluse	686.4M	897.6M	932.9M	1.0B	1.2B	659.2M
Other Current Assets	9.7M	6.6M	6.2M	10.1M	10.0M	7.4M
Other Stockholder Equity	897.6M	932.9M	1.0B	1.3B	1.3B	847.4M
Net Invested Capital	493.1M	300.6M	231.4M	271.8M	227.0M	245.3M
Net Working Capital	483.7M	291.9M	212.7M	254.9M	264.9M	287.5M
Property Plant And Equipment Net	16.1M	10.8M	9.9M	4.8M	5.1M	7.5M
Other Assets	1.0M	1.1M	680K	1.0	0.9	0.86
Property Plant And Equipment Gross	16.1M	15.1M	16.0M	10.2M	5.3M	9.3M
Accumulated Other Comprehensive Income	599K	45K	(574K)	(350K)	1.2M	1.2M
Property Plant Equipment	15.7M	5.5M	5.3M	4.0M	3.6M	5.4M
Capital Lease Obligations	11.3M	6.1M	6.4M	3.4M	5.4M	5.8M
Short Term Debt	3.6M	2.9M	14.6M	14.9M	961K	913.0K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Gossamer Stock Analysis

When running Gossamer Bio's price analysis, check to measure Gossamer Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gossamer Bio is operating at the current time. Most of Gossamer Bio's value examination focuses on studying past and present price action to predict the probability of Gossamer Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gossamer Bio's price. Additionally, you may evaluate how the addition of Gossamer Bio to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2025 Macroaxis LLC